$21.56+0.54 (+2.57%)
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally.
Nature's Sunshine Products, Inc. in the Consumer Defensive sector is trading at $21.56 with a market capitalization of $350M. Wall Street consensus targets $35.00 (2 analysts), implying a +62.3% move over the next 12 months. The stock is currently 23% below its 52-week high of $28.14, remaining 0.6% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 78 is overbought against a weak tape. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $122.89M↓ | $123.81M↓ | $128.34M↑ | $114.75M↑ | $113.25M |
| Gross Profit | $89.98M↑ | $89.78M↓ | $94.05M↑ | $82.30M↑ | $81.60M |
| Operating Income | $9.54M↑ | $5.32M↓ | $8.97M↑ | $4.27M↓ | $6.17M |
| Net Income | $5.12M↑ | $4.11M↓ | $5.33M | $5.33M↑ | $4.75M |
Nature's Sunshine Products, Inc., a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. The company distributes general health products...
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow.
Nature's Sunshine has been treading water for the past six months, recording a small loss of 4.7% while holding steady at $20.81. The stock also fell short of the S&P 500’s 7.8% gain during that period.
Analysts have recently raised their price targets for Nature's Sunshine Products while the model fair value stays put at US$35.00 per share, keeping the central valuation anchor unchanged. These higher targets are being linked to Q4 results that topped earlier expectations, broad regional strength, growing digital traction, and the view that the product portfolio is still under-penetrated in several key markets. Ahead, you will see how to track this evolving narrative and what to watch as...
The updated analyst narrative for Nature's Sunshine Products comes with a slightly higher fair value price target, moving from US$33 to US$35.00. That shift is tied to bullish analysts pointing to Q4 results coming in comfortably above consensus, a recurring "beat and raise" pattern, and what they see as ongoing opportunities in under penetrated markets and digital channels. As you read on, you will see how these views are evolving and what to watch if you are tracking this story...
The United States market has experienced a flat performance over the last week, yet it has seen a significant 24% increase over the past year with earnings projected to grow by 17% annually. In this dynamic environment, identifying stocks with strong fundamentals and growth potential can be key to uncovering undiscovered gems that may offer opportunities for investors.